1502PFirst line pembrolizumab for NSCLC with PD-L1 TPS >...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1502PFirst line pembrolizumab for NSCLC with PD-L1 TPS > 50% in a first French real life cohort

Amrane, K, Geier, M, Corre, R, Léveiller, G, Florence, G, Lamy, R, Bizec, J L, Goarant, E, Robinet, G, Ulrike, S, Quere, G, Bernier, C, Descourt, R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.024
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed